Pegylated Recombinant Human Granulocyte Colony-stimulating Factor
- Generic Name
- Pegylated Recombinant Human Granulocyte Colony-stimulating Factor
- Indication
⑴非髓性恶性肿瘤患者在接受会发生有临床意义发热性中性粒细胞减少的抑制骨髓的抗肿瘤药治疗时，使用本品可降低发热性中性粒细胞减少引起的感染发生率。
⑵本品不用于造血干细胞移植的外周血祖细胞的动员。
PEG-rhG-CSF in Patients With Malignant Solid Tumors Receiving Chemotherapy
- First Posted Date
- 2016-06-17
- Last Posted Date
- 2016-06-17
- Lead Sponsor
- CSPC Baike (Shandong) Biopharmaceutical Co., Ltd.
- Target Recruit Count
- 420
- Registration Number
- NCT02805166
PEG-rhG-CSF in Patients With Lymphoma Receiving Chemotherapy
- First Posted Date
- 2016-06-17
- Last Posted Date
- 2016-06-20
- Lead Sponsor
- CSPC Baike (Shandong) Biopharmaceutical Co., Ltd.
- Target Recruit Count
- 410
- Registration Number
- NCT02805218
PEG-rhG-CSF in Patients With Breast Cancer Receiving Chemotherapy to Prevent Neutropenia
- First Posted Date
- 2016-06-17
- Last Posted Date
- 2016-06-20
- Lead Sponsor
- CSPC Baike (Shandong) Biopharmaceutical Co., Ltd.
- Target Recruit Count
- 484
- Registration Number
- NCT02805205
PEG-rhG-CSF in Patients With Breast Cancer Receiving Chemotherapy
- First Posted Date
- 2016-06-17
- Last Posted Date
- 2016-06-20
- Lead Sponsor
- CSPC Baike (Shandong) Biopharmaceutical Co., Ltd.
- Target Recruit Count
- 215
- Registration Number
- NCT02805153
The Efficacy and Safety of PEG-rhG-CSF in Preventing Chemotherapy-induced Neutropenia
- First Posted Date
- 2016-05-04
- Last Posted Date
- 2017-06-01
- Lead Sponsor
- wang shusen
- Target Recruit Count
- 338
- Registration Number
- NCT02761460
- Locations
- 🇨🇳
Shusen Wang, Guangzhou, Guangdong, China
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath